SPC99

Úmeklidíníum brómíð

  • Status:
    Veitt
  • Application date:
    2.10.2014
  • Application published:
    15.10.2014
  • Grant published:
    15.7.2015
  • Max expiry date:
    29.4.2029
  • Next due date:
    30.4.2026
  • Medicine name:
    Incruse
  • Medicine for children:
    No

Timeline

Today
2.10.2014Application
15.10.2014Publication
15.7.2015Registration
26.4.2026Expires

Marketing license

  • IS authorization number:
    EU/1/14/922/001-003
  • Date:
    22.5.2014
  • Foreign authorization number:
    EU/1/14/922/001-003
  • Date:
    28.4.2014

Owner

  • Name:
    GLAXO GROUP LIMITED
  • Address:
    GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 11.4.2025

Expires: 26.4.2026

Payer: Árnason Faktor ehf.

Upload documents